Fierce Biotech December 8, 2023
Andrea Park

This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system. A mere 24 hours later, they’re already having to share the spotlight.

On Thursday, the day after Dexcom announced the Tandem team-up, Beta Bionics revealed that its technology, too, has been tapped to link with the G7 continuous glucose monitor. In this case, the resulting automated insulin delivery system will comprise Dexcom’s sensor plus Beta Bionics’ insulin pump and dosing software, which together have been dubbed the iLet Bionic Pancreas and were previously compatible only with Dexcom’s G6 sensor.

The iLet system was cleared by the FDA earlier this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
10 Ways To Drive Change In Healthcare
Regaining Speech: Implementing Neuroprosthetic Solutions
Baxter considers selling kidney care unit to private equity
Healthcare Spending 2000-2022: Key Trends, Five Important Questions
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks

Share This Article